US Patent 10597457 EGFRvIII antibody and composition comprising same
Patent 10597457 was granted and assigned to PharmAbcine on March, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 25, 2014
Date of Patent
March 24, 2020
Patent Applicant
Patent Application Number
15528753
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10597457 EGFRvIII antibody and composition comprising same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.